Kirin Holdings Co. Ltd. · TSE:2503
Kirin — Q2 2013 Earnings Presentation
14 slides from Kirin's earnings presentation, Aug 1, 2013
Slide 1: Kirin Group Financial Results for the Second Quarter of 2013
Kirin Group Financial Results for the Second Quarter of 2013 August 1, 2013 Kirin Holdings Company, Limited 1
Slide 2: Executive Summary
Executive Summary Increased sales and profits in the first half over previous year, and the highest sales ever Company performance driven by overseas top-line growth, and initiatives for renewed growth in Japan steadily implemented Net income targets set at the start of year unchanged. Operati
Slide 3: Second Quarter Performance Highlights
Second Quarter Performance Highlights YoY increased sales and profits driven by overseas top-line growth FY2013 FY2012 YoY change (Billion yen) (Billion yen) (Billion yen) (%) Japan integrated beverages 538.6 541.1 (2.4) (0.5) Sales and Operating Income Overseas integrated beverages 347.2 292.7 54.4
Slide 4: Annual Sales Forecast (revised on August 1, 2013)
Annual Sales Forecast (revised on August 1, 2013) Net income targets unchanged despite downward revision in pharmaceuticals and subsidiary’s share transfer FY2013 Difference to <Major differences to initial forecast> Revised Initial YoY change forecast (Billion yen) forecast (Billion yen) (Billion y
Slide 5: Reference: Updated Quantitative Targets
Reference: Updated Quantitative Targets (Normalized EBITDA) (Billion yen) (Normalized EPS) (Billion yen) FY2013 FY2013 FY2013 FY2013 FY2013 FY2013 Revised Initial Revised Initial Q2 Q2 forecast forecast forecast forecast Operating income 60.4 150.0 155.0 Net income 59.6 90.0 90.0 Depreciation 49.5 1
Slide 6: First-Half Review and Issues for the Achievement of Annual Targets
First-Half Review and Issues for the Achievement of Annual Targets Favorable Favorable overseas overseas growth growth and and steady steady implementation implementation of of measures measures for for renewed renewed growth growth in in Japan Japan Japan: Increasing brand value Achievements Achi
Slide 7: Japan Integrated Beverages: First Half Results
Japan Integrated Beverages: First Half Results Steady development of new measures for stronger brands FY2013 FY2012 YoY YoY Created drinking styles with new brand communication change change (Billion yen) (Billion yen) Concept shop Shop front (Billion yen) (%) Kirin Brewery 333.6 344.8 (11.1) (3.2)
Slide 8: Japan Integrated Beverages: Annual Forecast
Japan Integrated Beverages: Annual Forecast Achieve top-line goals by boosting key brands. Minimize cost increases due to changes in circumstances. Improve trend in Nodogoshi Nama sales FY2013 Difference YoY YoY Revised to initial change change ・ Maximize impact of new brand Forecast forecast commu
Slide 9: Lion: First Half Results
Lion: First Half Results Good progress in the Australian alcohol business boosts Lion’s performance, and group earnings increase realized F2013 F2012 YoY change Y o Y change(%) Bn Yen Mil AUD Bn Yen Mil AUD Bn Yen Mil AUD Yen basis AUD basis Alcohol 131.5 1,445 98.6 1,197 32.8 247 33.3 20.7 Soft Dri
Slide 10: Lion: Annual Forecast
Lion: Annual Forecast Aiming for the achievement of the original profit target FY2013 Difference to YoY change YoY change (%) Revised Forecast initial forecast Bn yen Mil AUD Bn yen Mil AUD Bn yen Mil AUD Yen basis AUD basis Alcohol 248.9 2,677 13.5 61 59.1 350 31.2 15.1 Soft Drink 234.3 2,519 2.5 (
Slide 11: Brasil Kirin: First Half Results
Brasil Kirin: First Half Results Achieved growth exceeding market by further boosting brand strengths through strategic investment FY2013 FY2012 YoY change YoY change (%) Bn yen Mil BRL Bn yen Mil BRL Bn yen Mil BRL Yen basis BRL basis Sales 84.0 1,798 69.8 1,627 14.1 170 20.3 10.5 Operating income
Slide 12: Brasil Kirin: Annual Forecast
Brasil Kirin: Annual Forecast Achieve the year goal of income by further reinforcement of sales and thorough cost control FY2013 Difference to initial YoY change YoY change (%) Revised forecast forecast Bn yen Mil BRL Bn yen Mil BRL Bn yen Mil BRL Yen basis BRL basis Sales 183.5 3,990 6.6 (122) 34.7
Slide 13: Pharmaceuticals and Bio-chemicals
Pharmaceuticals and Bio-chemicals Increased sales and profits Steady sales of pharmaceuticals domestically, and extensional growth of core products overseas. FY2013 Q2 FY2013 revised forecast Difference to YoY YoY YoY change YoY initial Billion yen change change Billion yen (Billion yen) change fore
Slide 14: This material is intended for informational purposes only
この資料は投資判断の参考となる情報の提供を目的としたものであり、投資勧誘を目的としたものではありません。 銘柄の選択、投資の最終決定は、ご自身の判断でなさるようにお願いいたします。 This material is intended for informational purposes only and is not a solicitation or offer to buy or sell securities or related financial instruments.
Kirin Holdings Company — Q2 2013 Earnings Presentation on 6ix